Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATEA PHARMACEUTICALS, INC.

(AVIR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ATEA PHARMACEUTICALS, INC.
01/17SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atea ..
PR
01/12Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Atea Pharmaceuticals, Inc. ..
BU
01/10ATEA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
01/07SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atea ..
PR
01/07Atea Pharmaceuticals Highlights Strategic Priorities for 2022
GL
01/07Atea Pharmaceuticals Highlights Strategic Priorities for 2022
GL
01/03Atea Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference
GL
2021Atea Pharmaceuticals Added to the Nasdaq Biotechnology Index
GL
2021Atea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 i..
GL
2021ATEA PHARMACEUTICALS, INC. : Regulation FD Disclosure (form 8-K)
AQ
2021Atea Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
GL
2021ATEA PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2021Atea Pharmaceuticals Provides Update on Strategic Collaboration with Roche
GL
2021ATEA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
2021Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2..
PU
2021Third Quarter 2021 Financial Results Conference Call Presentation
PU
2021Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2..
GL
2021Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2..
GL
2021Atea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on Novembe..
GL
2021Atea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on Novembe..
GL
2021ATEA PHARMACEUTICALS : Phase 2 MOONSONG Topline Results and Phase 3 MORNINGSKY Update Pres..
PU
2021ATEA PHARMACEUTICALS : Provides Update and Topline Results for Phase 2 MOONSONG Trial Eval..
AQ
2021ATEA PHARMACEUTICALS : to Present Virology and Early Clinical Data at the ISIRV-WHO Virtua..
AQ
2021ATEA PHARMACEUTICALS : to Present at Guggenheim 2nd Annual Vaccines & Infectious Day Confe..
AQ
2021Atea Pharmaceuticals to Present at the Morgan Stanley 19th Annual Global Healthcare Con..
GL
2021Atea Pharmaceuticals Announces Publication of Data Highlighting AT-752's Potent In Vitr..
GL
2021ATEA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021ATEA PHARMACEUTICALS : Second Quarter 2021 Financial Results Conference Call Presentation
PU
2021ATEA PHARMACEUTICALS : Provides Clinical and Corporate Update and Reports Second Quarter 2..
PU
2021ATEA PHARMACEUTICALS : Provides Clinical and Corporate Update and Reports Second Quarter 2..
AQ
2021Atea Pharmaceuticals to Host Second Quarter Financial Results Conference Call on August..
GL
2021ATEA PHARMACEUTICALS : Sublease Agreement, dated as of July 19, 2021, by and between the C..
PU
2021ATEA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Creation of a Dir..
AQ
2021Atea Pharmaceuticals to Present at William Blair Biotech Focus Conference
GL
2021Atea's AT-527, an Oral Antiviral Drug Candidate, Reduces Viral Replication in Hospitali..
GL
2021ATEA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K..
AQ
2021ROCHE : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under L..
AQ
2021Atea Pharmaceuticals Appoints Claudio Avila, MB, BS, Ph.D., as Senior Vice President of..
GL
2021Atea Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
GL
2021ATEA PHARMACEUTICALS : Initial Insider Trading Report (SEC Filing - 3)
PU
2021ATEA PHARMACEUTICALS : CONSULTING AGREEMENT (Form 8-K)
PU
2021ATEA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statemen..
AQ
2021Atea Pharmaceuticals Appoints Jerome Adams, M.D., M.P.H., to Board of Directors
GL
2021ATEA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021Atea Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporat..
GL
2021Atea Pharmaceuticals to Host First Quarter Financial Results Conference Call on May 13,..
GL
2021ATEA PHARMACEUTICALS : Announces First Patient Dosed in Global Phase 3 MORNINGSKY Trial of..
AQ
2021ATEA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021ATEA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021Atea Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Up..
GL
2021Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results Confer..
GL
2021Atea Pharmaceuticals Presents Favorable Phase 1 Results for AT-527 at 28th Annual Confe..
GL
2021Chugai Pharmaceutical Co., Ltd. - Chugai in-licenses New Oral Drug Candidate for COVID-..
AQ
2021Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment..
GL
2021Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Acti..
GL
2021Atea Pharmaceuticals Announces First Patient Dosed in Phase 2 Virology Trial of AT-527 ..
GL
2021Atea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Af..
GL
2020Atea Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference
GL
2020ATEA PHARMACEUTICALS : Added to Russell 2000 Index
AQ
2020ATEA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020ATEA PHARMACEUTICALS : to Present at Evercore ISI 3rd Annual HealthCONx Conference
AQ
2020Atea Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
GL
2020ATEA PHARMACEUTICALS : Expands Board of Directors with Appointment of Barbara Duncan
AQ
2020Atea Pharmaceuticals Expands Board of Directors with Appointment of Barbara Duncan
GL
2020ATEA PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Ye..
AQ
2020ATEA PHARMACEUTICALS : Announces Closing of Initial Public Offering
AQ
2020Atea Pharmaceuticals Announces Closing of Initial Public Offering
GL
2020Atea Pharmaceuticals Announces Pricing of Initial Public Offering
GL
Upcoming event on ATEA PHARMACEUTICALS, INC.
03/29/22